The Online Investor
OLI Premium
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com
ChartZero
Adamis Pharmaceuticals Corp. (ADMP)

Adamis Pharmaceuticals is a pharmaceutical company. Co. is primarily focused on developing its specialty pharmaceutical products: Epinephrine Injection USP 1:1000 0.3mg Pre-Filled Single Dose Syringe to deliver a premeasured dose of epinephrine for the treatment of anaphylaxis; APC-5000 dry powder inhaler for the treatment of asthma and chronic obstructive pulmonary disease (COPD); APC-1000 inhaler product for asthma and COPD; and APC-2000 for the treatment or prevention of bronchospasm. Co. also has a number of biotechnology product candidates and technologies, including therapeutic vaccine and cancer product candidates and technologies such as TeloB-VAX (vaccine) for prostate cancer.

Company Name:  Adamis Pharmaceuticals Corp.
Website:  www.adamispharmaceuticals.com
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding ADMP:  2
Total Market Value Held by ETFs:  $294158
Total Market Capitalization:  $147.00M
% of Market Cap. Held by ETFs:  0.20%
August 17, 2017    11:03 PM Eastern


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Quotes delayed 20 minutes



Strong Buy (4.00 out of 4)
98th percentile
(ranked higher than approx. 98% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Adamis Pharmaceuticals Corp. (ADMP) Page | The Online Investor | www.TheOnlineInvestor.com | Copyright © 1998 - 2017, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.